14235-45-1

Usage

Uses

Used in Cosmetic Industry:
4-isopropyl-m-phenylenediamine is used as a hair dye component for its ability to provide long-lasting and vibrant color to hair. It is often combined with other dyes to achieve a range of specific shades, enhancing the variety of color options available to consumers.
However, due to its potential allergenic and skin irritant properties, the use of 4-isopropyl-m-phenylenediamine in cosmetic products is strictly regulated in many countries to ensure consumer safety. This regulation is crucial to balance the aesthetic benefits of the compound with the need to protect users from potential adverse health effects.
Environmental Considerations:
The production and use of 4-isopropyl-m-phenylenediamine may also have environmental implications. Therefore, proper handling and disposal procedures are essential to minimize its impact on the environment, reflecting a responsible approach to chemical management in the cosmetics industry.

InChI:InChI=1/C9H14N2/c1-6(2)8-4-3-7(10)5-9(8)11/h3-6H,10-11H2,1-2H3

Upstream product

• 98-82-8 Isopropylbenzene 
• 89-07-6 1-isopropyl-2,4-dinitro-benzene 

Downstream Products

• 17022-08-1 4-isopropyl-m-phenylene diisocyanate 
• 873050-86-3 N-(3-amino-4-isopropylphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide 

Relevant academic research and scientific papers

NEW COMPOUND

PROBLEM TO BE SOLVED: To provide a new compound that does not have structural similarity to ceramide and has excellent CERT inhibitory activity. SOLUTION: The present invention provides a new compound of structural formula (I). A bond group -X- is cis-cyclopropyl-, R1, R2, R3, R4, and R5 independently represent a hydrogen atom, a halogen atom, a linear or branched C1-C8 alkyl group that may have a halogen atom, or OR6. SELECTED DRAWING: Figure 1 COPYRIGHT: (C)2020,JPOandINPIT

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES

The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

Synthesis of phthalonitrile resins containing ether and imide linkages

Imide-containing phthalonitrile monomers are prepared from a phthalonitrile and an aromatic dianhydride. The monomer and a method for preparing the monomer is disclosed. These monomers are synthesized into heat resistant polymers and copolymers with aromatic ring structure incorporating imide and ether linkages. The synthesis of the high temperature thermosetting polymers and copolymers is also disclosed.

Silicone containing bis-thioether aromatic amines

A silicone containing bis-thioether aromatic amine has a chemical structure wherein an aromatic nucleus at each end of the chemical radical is chemically bonded to the remainder of the chemical radical by either sulfur, sulfoxide or sulfone.